1. Home
  2. CDMO vs RAPP Comparison

CDMO vs RAPP Comparison

Compare CDMO & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDMO
  • RAPP
  • Stock Information
  • Founded
  • CDMO 1981
  • RAPP 2022
  • Country
  • CDMO United States
  • RAPP United States
  • Employees
  • CDMO N/A
  • RAPP N/A
  • Industry
  • CDMO Biotechnology: Pharmaceutical Preparations
  • RAPP
  • Sector
  • CDMO Health Care
  • RAPP
  • Exchange
  • CDMO Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • CDMO 793.8M
  • RAPP 844.6M
  • IPO Year
  • CDMO N/A
  • RAPP 2024
  • Fundamental
  • Price
  • CDMO $12.39
  • RAPP $12.69
  • Analyst Decision
  • CDMO Hold
  • RAPP Strong Buy
  • Analyst Count
  • CDMO 3
  • RAPP 4
  • Target Price
  • CDMO $12.25
  • RAPP $37.33
  • AVG Volume (30 Days)
  • CDMO 1.3M
  • RAPP 119.0K
  • Earning Date
  • CDMO 12-10-2024
  • RAPP 02-10-2025
  • Dividend Yield
  • CDMO N/A
  • RAPP N/A
  • EPS Growth
  • CDMO N/A
  • RAPP N/A
  • EPS
  • CDMO N/A
  • RAPP N/A
  • Revenue
  • CDMO $150,445,000.00
  • RAPP N/A
  • Revenue This Year
  • CDMO $19.05
  • RAPP N/A
  • Revenue Next Year
  • CDMO $20.88
  • RAPP N/A
  • P/E Ratio
  • CDMO N/A
  • RAPP N/A
  • Revenue Growth
  • CDMO 6.75
  • RAPP N/A
  • 52 Week Low
  • CDMO $5.90
  • RAPP $12.10
  • 52 Week High
  • CDMO $12.48
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • CDMO 61.55
  • RAPP N/A
  • Support Level
  • CDMO $12.37
  • RAPP N/A
  • Resistance Level
  • CDMO $12.45
  • RAPP N/A
  • Average True Range (ATR)
  • CDMO 0.04
  • RAPP 0.00
  • MACD
  • CDMO -0.02
  • RAPP 0.00
  • Stochastic Oscillator
  • CDMO 71.43
  • RAPP 0.00

About CDMO Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: